← Catalog / Genomics / PGx CIViC Evidence v1

PGx CIViC Evidence v1

⚠ Research onlyGenomicsGenomic
10,000
Records
2026-04-03
Last updated
14 cols
Schema fields
84
Attester Quality Score
How we score →

PGx CIViC Evidence v1 is a pharmacogenomics dataset derived from the Clinical Interpretation of Variants in Cancer (CIViC) knowledgebase, containing curated evidence linking genomic variants to drug responses, resistance mechanisms, and clinical outcomes in oncology. It aggregates expert-reviewed, literature-sourced evidence items associating specific somatic and germline variants with therapeutic relevance across cancer types. This resource supports precision medicine research by providing structured, community-curated variant-drug associations with associated evidence levels and clinical significance ratings.

Recommended use cases
Training and validating pharmacogenomics AI/ML models for drug response prediction
Developing clinical decision support tools for oncology precision medicine
Conducting systematic research on variant-drug interaction landscapes in cancer genomics
Benchmarking variant interpretation pipelines and annotation tools